(Q53537196)

15 May 2018

title

Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits. (English)

1 reference

15 May 2018

author name string

Zhou-Jun Shen

1

1 reference

15 May 2018

Yi Wang

2

1 reference

15 May 2018

Guo-Qing Ding

3

1 reference

15 May 2018

Chun-Wu Pan

4

1 reference

15 May 2018

Rong-Ming Zheng

5

1 reference

15 May 2018

publication date

13 July 2007

1 reference

15 May 2018

published in

World Journal of Urology

1 reference

15 May 2018

volume

25

1 reference

15 May 2018

page(s)

525-529

1 reference

15 May 2018

issue

5

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s00345-007-0198-z

exact match

0 references

cites work

Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response

1 reference

12 December 2020

Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAP

1 reference

12 December 2020

Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG

1 reference

12 December 2020

Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity

1 reference

12 December 2020

The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis

1 reference

12 December 2020

Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group

1 reference

12 December 2020

Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors

1 reference

12 December 2020

Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.

1 reference

12 December 2020

Internalization of bacille Calmette-Guerin by bladder tumor cells.

1 reference

12 December 2020

Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer

1 reference

12 December 2020

Fibronectin enhances healing of excised wounds in rats

1 reference

12 December 2020

Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin

1 reference

12 December 2020

Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin

1 reference

12 December 2020

BCG intravesical instillations: recommendations for side-effects management

1 reference

12 December 2020

Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer

1 reference

12 December 2020

Enhancement of Bacillus Calmette-Guerin Attachment to the Urothelium by Removal of the Rabbit Bladder Mucin Layer

1 reference

12 December 2020

Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer

1 reference

12 December 2020

Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials

1 reference

12 December 2020

Mechanisms of BCG action. I. The induction of nonspecific helper cells during the potentiation of alloimmune cell-mediated cytotoxic responses

1 reference

12 December 2020

Modulation of fibronectin-mediated Bacillus Calmette-Guérin attachment to murine bladder mucosa by drugs influencing the coagulation pathways

1 reference

12 December 2020

Mechanism of interaction of the 85B secreted protein of Mycobacterium bovis with fibronectin.

1 reference

12 December 2020

Distribution of Fibronectin During Wound Healing in Vivo

1 reference

12 December 2020

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer

1 reference

12 December 2020

Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma

1 reference

12 December 2020

Role of a bacillus Calmette-Guérin fibronectin attachment protein in BCG-induced antitumor activity

1 reference

12 December 2020

Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors

1 reference

12 December 2020

Role of fibronectin in intravesical BCG therapy for superficial bladder cancer

1 reference

12 December 2020

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

1 reference

12 December 2020

Current recommendations for the management of bladder cancer. Drug therapy

1 reference

12 December 2020

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

1 reference

12 December 2020

Requirement of a thymus dependent immune response for BCG-mediated antitumor activity

1 reference

12 December 2020

Tissue debris at the injury site is coated by plasma fibronectin and subsequently removed by tissue macrophages

1 reference

12 December 2020

Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer

1 reference

12 December 2020

10.1007/S00345-007-0198-Z

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

17665201

1 reference

15 May 2018